Stocks · News reference
Cantor Fitzgerald analyst Steve Seedhouse maintains Innoviva (NASDAQ:INVA) with a Overweight and lowers the price target from $36 to $34.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Innoviva (NASDAQ:INVA) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $0.40 by 385 percent. This is a 248.05 percent decrease over earnings of $0.77 per share from the same
Read original at benzingaFiled: 2026-08-05 AccNo: 0001193125-26-335192 Size: 257 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgar